The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.


Cem O., Sedef A. M. , Kose F., Oymak E., Guler O. C. , Sumbul A. T. , ...More

ASCO-SITC Clinical Immuno-Oncology Symposium, San-Francisco, Costa Rica, 28 February - 02 March 2019, vol.37 identifier